Literature DB >> 22404863

Early vocalization of preterm infants with extremely low birth weight (ELBW), Part I: From birth to expansion stage.

Helena Törölä1, Matti Lehtihalmes, Hanna Heikkinen, Päivi Olsén, Anneli Yliherva.   

Abstract

The vocalization of preterm infants with extremely low birth weight (ELBW) up to the expansion stage was systematically described and compared with those of healthy full-term infants. The sample consisted of 18 preterm ELBW infants and the control group of 11 full-term infants. The follow-up was performed intensively using video-recordings. The vocalization of the preterm and full-term infants was analyzed quantitatively according to the categorical stages created by Oller. A descriptive analysis of all the vocalizations produced by the infants was performed. The preterm infants entered the primitive articulation stage later than the full-term infants and failed to produce more skills during that stage. According to this sample, there was no difference in entering the expansion stage, but the preterm infants failed to produce more skills than the full-term infants. The number of vocalization acts varied differently by age between the groups.

Entities:  

Mesh:

Year:  2012        PMID: 22404863     DOI: 10.3109/02699206.2011.636499

Source DB:  PubMed          Journal:  Clin Linguist Phon        ISSN: 0269-9206            Impact factor:   1.346


  3 in total

1.  The Relationship Between the Onset of Canonical Syllables and Speech Perception Skills in Children With Cochlear Implants.

Authors:  Jongmin Jung; Derek Houston
Journal:  J Speech Lang Hear Res       Date:  2020-02-11       Impact factor: 2.297

2.  Uneven Linguistic Outcome in Extremely Preterm Children.

Authors:  P De Stefano; M Marchignoli; F Pisani; G Cossu
Journal:  J Psycholinguist Res       Date:  2019-12

3.  Volubility of the human infant: Effects of parental interaction (or lack of it).

Authors:  Suneeti Nathani Iyer; Hailey Denson; Nicole Lazar; D Kimbrough Oller
Journal:  Clin Linguist Phon       Date:  2016-03-22       Impact factor: 1.346

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.